For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed the day trading at $10.63 down -1.85% from the previous closing price of $10.83. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 0.56 million shares were traded. AVDL stock price reached its highest trading level at $10.925 during the session, while it also had its lowest trading level at $10.53.
Ratios:
For a better understanding of AVDL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.51.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On June 12, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $27.Rodman & Renshaw initiated its Buy rating on June 12, 2024, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1030052288 and an Enterprise Value of 1002232896. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.30 while its Price-to-Book (P/B) ratio in mrq is 13.87. Its current Enterprise Value per Revenue stands at 5.154 whereas that against EBITDA is -61.112.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.48, which has changed by -0.34944922 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $17.30, while it has fallen to a 52-week low of $6.38. The 50-Day Moving Average of the stock is 9.75%, while the 200-Day Moving Average is calculated to be 9.03%.
Shares Statistics:
Over the past 3-months, AVDL traded about 1.38M shares per day on average, while over the past 10 days, AVDL traded about 1112180 shares per day. A total of 96.63M shares are outstanding, with a floating share count of 88.51M. Insiders hold about 8.65% of the company’s shares, while institutions hold 77.00% stake in the company. Shares short for AVDL as of 1752537600 were 12312691 with a Short Ratio of 8.93, compared to 1749772800 on 10615388. Therefore, it implies a Short% of Shares Outstanding of 12312691 and a Short% of Float of 14.840000999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
